Sharon Diskin Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• Overview of neuroblastoma epidemiology and genetic predisposition — Neuroblastoma Update - 1
• Can germline and somatic mutations (or rare variants) help us identify "ultra-high risk" neuroblastoma and predict patient outcomes? — Workshop 4 - Next generation risk stratification: new approaches to identify highest risk patients (or ultra high risk patients)